Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial
Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the page, and the prior Revision: v3.4.1 reference along with the government funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedAn administrative update adds a site-wide government funding notice and the page revision tag (v3.4.1); these changes do not affect study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedA 'Show glossary' option was added, and new metadata items Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were introduced. The older metadata labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows Revision: v3.3.4 instead of Revision: v3.3.3.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded extensive Locations entries across CA, CO, FL, IL, KS, MA, MI, MN, NV, NJ, NY, TX, VT, WV, and United Kingdom, and updated the page to Revision 3.3.3. The HHS Vulnerability Disclosure section and the v3.3.2 revision entry were removed.SummaryDifference1%

Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.